.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Wide-awake local anaesthesia with no tourniquet has gained popularity in hand surgery because it can simplify care, reduce anaesthetic requirements and allow intraoperative assessment of tendon function. This randomized clinical trial compared WALANT with forearm tourniquet Bier block anaesthesia for minor hand procedures. Both techniques provided effective anaesthesia, supporting WALANT as a practical alternative in appropriately selected patients. The broader value of the study is operational as well as clinical: WALANT can reduce dependence on operating-room resources and may improve workflow for procedures that do not require general or regional anaesthesia. Patient selection remains important, particularly in individuals with anxiety, intolerance of an awake procedure or complex surgery. The evidence also supports the basic safety principle behind WALANT—careful dosing, appropriate patient monitoring and familiarity with local anaesthetic technique. For HCPs, the message is that the traditional assumption that a tourniquet-based block is required for minor hand surgery is increasingly difficult to justify universally. WALANT can be incorporated into a day-surgery pathway when the procedure, patient and surgical team are all suited to the approach.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Wide-awake local anaesthesia with no tourniquet has gained popularity in hand surgery because it can simplify care, reduce anaesthetic requirements and allow intraoperative assessment of tendon function. This randomized clinical trial compared WALANT with forearm tourniquet Bier block anaesthesia for minor hand procedures. Both techniques provided effective anaesthesia, supporting WALANT as a practical alternative in appropriately selected patients. The broader value of the study is operational as well as clinical: WALANT can reduce dependence on operating-room resources and may improve workflow for procedures that do not require general or regional anaesthesia. Patient selection remains important, particularly in individuals with anxiety, intolerance of an awake procedure or complex surgery. The evidence also supports the basic safety principle behind WALANT—careful dosing, appropriate patient monitoring and familiarity with local anaesthetic technique. For HCPs, the message is that the traditional assumption that a tourniquet-based block is required for minor hand surgery is increasingly difficult to justify universally. WALANT can be incorporated into a day-surgery pathway when the procedure, patient and surgical team are all suited to the approach.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
